NCT01753908
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +25 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Invasive Breast Carcinoma
Explore clinical trials studying Invasive Breast Carcinoma. Study availability and eligibility vary by location and protocol.
89 public trials
19 recruiting studies
Invasive Breast Carcinoma trial results
NCT01964924
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Completed
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer
NCT02370277
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +17 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT01434303
- Conditions
- Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01344031
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +7 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT00429182
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +11 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
NCT02954874
- Conditions
- Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
Active, Not Recruiting
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
NCT02445391
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
- Locations
-
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer
NCT02912312
- Conditions
- Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +12 more
- Locations
-
- MD Anderson Cancer Center (Banner) Gilbert, Arizona, United States
- Scripps- MD Anderson Cancer San Diego, California, United States
- MD Anderson Cancer Center (Banner)- Northern Colorado Greeley, Colorado, United States
- Baptist - MD Anderson Cancer Center Jacksonville, Florida, United States